genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
Clinical trial
Bioprocessing
Standardizing CGT Supply Chain Management
Cancer
Patient Glioblastoma Response to CAR-T Cell Therapy Mirrored in Tumor-Derived Organoids in Real Time
Cancer
Lymphoma Immunotherapy Enhanced by Enzyme Inhibitor In Preclinical Model, Prompting Pilot Clinical Studies
GEN Edge
Going Public: Doudna’s Dream Team Launches Groundbreaking Sickle Cell Trial
Cancer
CAR T Cells Armed with IL-15 Show Promise in Solid Cancer Therapy
Drug Discovery
Bridgebio’s Attruby, to Treat Heart Condition ATTR-CM, Receives FDA Approval
Artificial Intelligence
Xiaorong He on Boehringer Ingelheim’s Investments in AI, Broader Applications in Pharma
Cancer
Aggressive Tumor Growth in Drug-Resistant Prostate Cancer Driven by Enzyme
Bioprocessing
Asimov and RevOpsis Therapeutics Ink Licensing Deal for Multispecific-Expressing Cell Line
Cancer
CAR T-Cells Use SNIPR Technology to Confirm Cancer Targets before Firing
1
2
3
...
273
Page 1 of 273
Scroll Up